发布于: 修改于: Android转发:0回复:0喜欢:0

$DICE Therapeutics(DICE)$

礼来24亿美元收购小分子自免新药。IL-17以及

α4ß7 整合素和 αVß1/αVß6 整合素的口服治疗候选药物。

DICE announced a definitive agreement for LLY to acquire Dice. Lilly will acquire all outstanding shares of DICE for $48/share in cash for ~$2.4bn